CBU
HUMA icon

CIBC Bancorp USA’s Humacyte HUMA Stock Holding History

CIBC Bancorp USA’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$23.2K Buy
+13,360
New +$26.2K ﹤0.01% 1449

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CIBC Bancorp USA's HUMA Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Humacyte (HUMA) in Q3 2025: 13,360 shares worth $23.2K. The stake represents ﹤0.01% of the portfolio and ranks #1449 among its holdings.

141 funds tracked by Wall St. Rank hold HUMA as of Q3 2025.

  • CIBC Bancorp USA held 13,360 shares of Humacyte worth $23.2K as of Q3 2025.
  • Humacyte was a new CIBC Bancorp USA position in Q3 2025.
  • Humacyte made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1449 holding.
  • 141 funds tracked by Wall St. Rank held Humacyte as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.